Projects we fund
Find out more about the research projects you’re helping us to fund, to create a better future for children with neuroblastoma.
 
                        
                        
                                    Senior Neuroblastoma Clinical Trials Coordinator
                                
                                
                                    Solving Kid's Cancer UK has funded a specialised Senior Clinical Trials Coordinator post at the Cancer Research Clinical Trials Unit in Birmingham dedicated to working on trials for neuroblastoma.
 
                        
                        
                                    Phase III TITAN trial
                                
                                
                             
                        
                        
                                    Solving Indolent Neuroblastoma
                                
                                
                             
                        
                        
                                    Europe-wide frontline high-risk neuroblastoma trial
                                
                                
                             
                        
                        
                                    Phase I MiNivAn trial
                                
                                
                             
                        
                        
                                    Phase I trial of ALK inhibitor Lorlatinib
                                
                                
                             
                        
                        
                                    CAR-T cells for treatment of neuroblastoma
                                
                                
                             
                        
                        
                                    Identifying markers of poor survival in high-risk neuroblastoma
                                
                                
                             
                        
                        
                                    Evaluating biomarkers of neuroblastoma in the BEACON trial
                                
                                
                             
                        
                        
                                    Introducing immunotherapy into the BEACON trial for high-risk neuroblastoma
                                
                                
                             
                        
                        
                                    Optimizing Immunotherapy for chemo-resistant neuroblastoma